Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alfredo Paredes, MD
Hospital de Donostia
Principal Investigator - Ana Laura Ortega, MD
Hospital de Jaén
Principal Investigator - Bartomeu Massutí, MD
Hospital General Universitario de Alicante
Principal Investigator - David Vicente, MD
Hospital Universitario Virgen Macarena
Principal Investigator - Dolores Isla, MD
Hospital Lozano Blesa
Principal Investigator - José Luis González Larriba, MD
Hospital San Carlos, Madrid
Principal Investigator - José Miguel Sánchez, MD
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Principal Investigator - Juan Coves, MD
Hospital Son Llátzer
Principal Investigator - Manuel Dómine, MD
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Principal Investigator - Margarita Majem, MD
Hospital Sant Pau i de la Santa Creu
Principal Investigator - Mariano Provencio, MD
Hospital Puerta de Hierro
Study Chair - María Guirado, MD
Hospital Gnral de Elche
Principal Investigator - Mª Angeles Sala, MD
Hospital de Basurto
Principal Investigator - Ramón de las Peñas, MD
Hospital Provincial de Castellón
Principal Investigator - Raquel Marsé, MD
Hospital Son Espases
Principal Investigator - Regina Gironés, MD
Hospital LLuís Alcanyís
Principal Investigator - Sergio Vázquez, MD
Hospital Lucus Agustí
Principal Investigator - Teresa Morán, MD
Germans Trias i Pujol Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital General Universitario de Elche
Elche, Alicante, Spain
- Ico-Badalona
Badalona, Barcelona, Spain
- Hospital Provincial de Castellón
Castellon, Castelló, Spain
- H. Son Espases
Palma de Mallorca, Mallorca, Spain
- Hospital Lluís Alcanyís
Xàtiva, Valencia, Spain
- Hospital de Basurto
Bilbao, Vizcaya, Spain
- H.G.U. Alicante
Alicante, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- H. de Donostia
Donostia / San Sebastian, Spain
- Hospital de Jaén
Jaén, Spain
- Hospital Universitario Lucus Augusti
Lugo, Spain
- H. Clínico San Carlos
Madrid, Spain
- H. de la Princesa
Madrid, Spain
- H.U. Puerta de Hierro
Madrid, Spain
- Hospital Fundación Jiménez Díaz
Madrid, Spain
- H. Son Llàtzer
Palma de Mallorca, Spain
- Hospital Virgen de la Macrena
Seville, Spain
- Hospital Clínico Lozano Blesa
Zaragoza, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Apr 2016
- Primary completion
- 15 Apr 2019
- Completion
- 16 Dec 2019
- Last update posted
- 11 Jan 2024
- Registered enrollment
- 68
- Registry id
- NCT02709720
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.